These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 16173958)
1. Central nervous system-directed preventative therapy in adults with lymphoma. McMillan A Br J Haematol; 2005 Oct; 131(1):13-21. PubMed ID: 16173958 [TBL] [Abstract][Full Text] [Related]
2. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E; Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036 [TBL] [Abstract][Full Text] [Related]
3. CNS prophylaxis in lymphoma: who to target and what therapy to use. Hill QA; Owen RG Blood Rev; 2006 Nov; 20(6):319-32. PubMed ID: 16884838 [TBL] [Abstract][Full Text] [Related]
4. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977 [TBL] [Abstract][Full Text] [Related]
5. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview]. Thomas X; Pavan L; Le QH Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650 [TBL] [Abstract][Full Text] [Related]
6. CXCL13 and CXCL12 in central nervous system lymphoma patients. Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group. Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X; Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120 [TBL] [Abstract][Full Text] [Related]
8. [Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas]. Kumiega B; Jurczak W; Fornagiel S; Dzietczenia J; Skotnicki AB Przegl Lek; 2013; 70(4):187-90. PubMed ID: 23991555 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement. Lee KW; Yi J; Choi IS; Kim JH; Bang SM; Kim DW; Im SA; Kim TY; Yoon SS; Lee JS; Bang YJ; Park S; Kim BK; Cho HI; Heo DS Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274 [TBL] [Abstract][Full Text] [Related]
10. Secondary central nervous system lymphoma: risk factors and prophylaxis. Montoto S; Lister TA Hematol Oncol Clin North Am; 2005 Aug; 19(4):751-63, viii. PubMed ID: 16083835 [TBL] [Abstract][Full Text] [Related]
12. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Rizzieri DA; Johnson JL; Niedzwiecki D; Lee EJ; Vardiman JW; Powell BL; Barcos M; Bloomfield CD; Schiffer CA; Peterson BA; Canellos GP; Larson RA Cancer; 2004 Apr; 100(7):1438-48. PubMed ID: 15042678 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma. Mason JO; Fischer DH Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254 [TBL] [Abstract][Full Text] [Related]
15. Leukemia and lymphoma: what is the role for intrathecal prophylactic treatment in adults? Garcia-Manero G; Glantz M Expert Rev Neurother; 2004 Jul; 4(4 Suppl):S25-31. PubMed ID: 15853552 [TBL] [Abstract][Full Text] [Related]
16. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110 [TBL] [Abstract][Full Text] [Related]
17. [Paraplegia following intrathecal chemotherapy]. Beretta F; Sanna P; Ghielmini M; Marini G; Cavalli F Schweiz Med Wochenschr; 1996 Jun; 126(25):1107-11. PubMed ID: 8711459 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588 [TBL] [Abstract][Full Text] [Related]
19. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Pui CH; Thiel E Semin Oncol; 2009 Aug; 36(4 Suppl 2):S2-S16. PubMed ID: 19660680 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]